NCT00033293
Clinical Trial Information
Trial Number: NCT00033293 (ClinicalTrials.gov)
Disease Type:
- CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
Trial Title:
A Pilot Study Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone
Study ID:
ANBL00P3
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00033293-D3 | There are three datasets: NCT00033293-D1 NCT00033293-D2 and NCT00033293-D3 for PMID 29376112. USI is the patient identifier in all datasets. NCT00033293-D3 There is one row for each patient used to create Supplemental Table 2 of the manuscript. The dataset provides the information necessary to reproduce the distribution of OMA scores by symptom and time point. |
| NCT00033293-D2 | There are three datasets: NCT00033293-D1 NCT00033293-D2 and NCT00033293-D3 for PMID 29376112. USI is the patient identifier in all datasets. NCT00033293-D2 Each row represents one adverse event used in the manuscript or one row per patient if no adverse event of interest was experienced. These data provide specific incidence of adverse events of interest to recreate Table 3 found in the manuscript. |
| NCT00033293-D1 | There are three datasets: NCT00033293-D1 NCT00033293-D2 and NCT00033293-D3 for PMID 29376112. USI is the patient identifier in all datasets. NCT00033293-D1 There is one row for each patient enrolled on ANBL00P3. The dataset provides the information necessary to reproduce patient baseline characteristics, evaluability, treatment received, disease response, and survival. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®